EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Timing of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: Evidence, Mechanisms, and the Emerging Role of Timely ICD‐Guided Intervention

Federico Turreni iD, Luca Santini iD, Maria Luisa Loricchio, Antonio Castro, Raffaello Molino Lova, Ignacio Garcia Bolao, Francesco Solimene, Antonino Granatelli, Marzia Giaccardi, Andrea Colella, Tania Chechi, Riccardo Cappato iD

Journal of Cardiovascular Electrophysiology · 2026-07 · 37 (7) · 1577-1587

DOI: 10.1111/jce.70390 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 02.06.2026. Verfasst von Federico Turreni und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Santa Maria della Stella Hospital, Orvieto, Italy. Hauptthemen laut MEDLINE: Catheter Ablation, Tachycardia, Ventricular, Defibrillators, Implantable, Cardiomyopathies. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The optimal timing of catheter ablation for ventricular tachycardia (VT) in ischemic cardiomyopathy remains uncertain, with strategies ranging from prophylactic intervention to delayed treatment after recurrent arrhythmia. Increasing evidence suggests that the timing of ablation may critically influence both arrhythmic and clinical outcomes.

Objective

To synthesize contemporary evidence on VT ablation timing and to examine the mechanistic and clinical rationale supporting a timing‐oriented therapeutic framework.

Methods

We performed a structured narrative review of randomized trials, observational studies, and mechanistic investigations evaluating different ablation strategies, including prophylactic, early, and ICD‐guided approaches. Particular emphasis was placed on integrating clinical outcomes with experimental and imaging data on post‐infarct substrate evolution.

Results

Prophylactic ablation reduces arrhythmic burden but has not demonstrated consistent survival benefit. Early ablation strategies improve procedural outcomes but are limited by heterogeneous definitions and inconsistent prognostic impact. By contrast, a timely ICD‐guided approach—based on the first device‐verified arrhythmic event—has demonstrated consistent reductions in VT recurrence and ICD therapies, with emerging but heterogeneous signals of survival benefit in randomized trials. Mechanistic evidence supports this paradigm, showing that the post‐infarct scar is dynamic and continues to remodel over time, with increasing arrhythmogenic complexity. The first ICD‐treated arrhythmia may therefore represent a biologically meaningful inflection point for intervention. Imaging and computational tools can refine patient selection and procedural planning after this trigger, while emerging ablation technologies may expand treatment options but do not modify timing strategies.

Conclusions

A timing‐oriented approach to VT ablation, anchored to clinically meaningful ICD‐verified arrhythmic events, provides the most coherent integration of mechanistic insight and clinical evidence. This strategy may also have relevant implications for healthcare utilization, although formal cost‐effectiveness data remain limited. Future work should focus on refining patient selection within this therapeutic window and evaluating how evolving technologies can be integrated without compromising the central importance of timing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Catheter AblationTachycardia, VentricularDefibrillators, ImplantableCardiomyopathiesMyocardial IschemiaTime-to-TreatmentElectric CountershockHumansTime FactorsTreatment OutcomeRisk FactorsRecurrenceHeart RateTreatment Delay

Autor:innen und Institutionen

  • Cardiology Division, Santa Maria della Stella Hospital, Orvieto, Italy.
  • Cardiology Unit, Sandro Pertini Hospital, Rome, Italy.
  • Cardiology Unit, G.B. Grassi Hospital, Rome, Italy.
  • Private Practice, Florence, Italy.
  • Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain.
  • Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.

ORCID-Profile: Federico Turreni, Luca Santini, Riccardo Cappato

Zitieren

APA

Turreni, F., Santini, L., Loricchio, M. L., Castro, A., Lova, R. M., Bolao, I. G., Solimene, F., Granatelli, A., Giaccardi, M., Colella, A., Chechi, T., & Cappato, R. (2026). Timing of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: Evidence, Mechanisms, and the Emerging Role of Timely ICD‐Guided Intervention. Journal of Cardiovascular Electrophysiology, 37(7), 1577-1587. https://doi.org/10.1111/jce.70390

Vancouver

Turreni F, Santini L, Loricchio ML, Castro A, Lova RM, Bolao IG, et al. Timing of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: Evidence, Mechanisms, and the Emerging Role of Timely ICD‐Guided Intervention. Journal of Cardiovascular Electrophysiology. 2026;37(7):1577-1587. doi:10.1111/jce.70390

BibTeX
@article{Turreni2026,
  author = {Turreni, Federico and Santini, Luca and Loricchio, Maria Luisa and Castro, Antonio and Lova, Raffaello Molino and Bolao, Ignacio Garcia and Solimene, Francesco and Granatelli, Antonino and Giaccardi, Marzia and Colella, Andrea and Chechi, Tania and Cappato, Riccardo},
  title = {Timing of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: Evidence, Mechanisms, and the Emerging Role of Timely ICD‐Guided Intervention},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  volume = {37},
  number = {7},
  pages = {1577--1587},
  doi = {10.1111/jce.70390}
}
Kostenlos starten →